DESHLER, OHIO--(Business Wire / Korea Newswire)--Graminex®, L.L.C. is pleased to announce publication of a peer reviewed clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health in Current Urology. The study was conducted as a randomized, double-blind, placebo-controlled study to investigate the effectiveness of Graminex® Flower Pollen Extracts in 114 healthy women with urinary incontinence. It was concluded that significant and meaningful reductions in UI severity were found in the Graminex® RCT Fem™ UI study group along with significant improvement in stress-induced urinary leakage volume with the PollenBerry® study group. A full version is available at: Current Urology - Original Article

“Many women experience urinary incontinence throughout their lives during postpartum, menopause, and the natural aging process. There is limited natural support to help improve the symptoms of urinary incontinence currently on the market. With this peer reviewed publication, Graminex is excited to offer a natural product to help improve women’s lives, when it’s needed most,” said Colleen May, CBO.

About Graminex®, L.L.C.

Graminex®,L.L.C. is the leading producer of natural and non-solvent Graminex® Flower Pollen Extract™. Graminex® directly owns and manages more than 6500 acres of farmland in Northwest Ohio to meet its customer’s needs. Graminex’s active ingredients are grown and processed for the dietary supplement, nutraceutical, pharmaceutical, food and skin care industries. Graminex® markets its own branded line of raw materials and dietary supplements, focusing on prostate care, urinary care, menopausal support, and skin care.

For further information please contact Graminex®,L.L.C., Colleen May at +1 (419) 278-1023 or by e-mail at [email protected]. You may also visit www.graminex.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240513362788/en/

Website: http://www.graminex.com View Korean version of this release Contact Graminex®, L.L.C.
Chief Business Officer
Colleen E. May
+1 (419) 278-1023
[email protected]
This news is a press release provided by Graminex® L.L.C.. Korea Newswire follows these editorial guidelines. Graminex® L.L.C. News ReleasesSubscribeRSS 그래미넥스®, 여성의 요실금에 초점 맞춘 그래미넥스® 플라워 폴렌 익스트렉트를 사용한 동료 검토 임상 시험을 현재 비뇨기과학에 최종 발표 그래미넥스®(Graminex®, LLC)가 현재 비뇨기과학(Current Urology)에서 여성의 요실금 및 비뇨기 건강을 위한 그래미넥스® 플라워 폴렌 익스트렉트(Graminex® Flower Pollen Extract)에 대한 동료 검토 임상 시험의 출판을 하게 된 것을 기쁘게 생각한다. 이 시험은 요실금이 있는 114명의 건강한 여성을 대상... 5월 14일 14:10 Graminex® Rye Pollen Achieves Novel Food Registration in China and Appoints Guangzhou Narnia Biotechnology as Their Authorized Distribution Partner Graminex® announced today that it has achieved novel food registration in China for Rye Pollen and appointed Guangzhou Narnia Biotechnology as its distribution partner in China. Graminex®, based in the United States, is the exclusive grower and manufacturer of rye pollen and a leader in... 2023년 8월 9일 09:40 ... More  More News Health Health Functional Food R&D Overseas Graminex® L.L.C. All News Releases 